Neopterin, soluble IL-2 receptor and IL-6 secretion during IL-2 cancer immunotherapy: prognostic significance in relation to IL-12 variations.

Authors :: Lissoni P
Barni S
Di Felice G
Majorca F
Fumagalli L
Source :: The International journal of biological markers [Int J Biol Markers] 1997 Jul-Sep; Vol. 12 (3), pp. 134-6.
Publication Year :: 1997

Subjects :: Adult
Aged
Carcinoma, Renal Cell blood
Humans
Immunotherapy
Kidney Neoplasms blood
Middle Aged
Prognosis
Solubility
Adjuvants, Immunologic therapeutic use
Carcinoma, Renal Cell drug therapy
Interleukin-12 blood
Interleukin-2 therapeutic use
Interleukin-6 metabolism
Kidney Neoplasms drug therapy
Neopterin blood
Receptors, Interleukin-2 blood

Full Text Access

Tools